tasosartan has been researched along with angiotensin ii in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antane, M; Bagli, JF; Chen, J; Collini, MD; Ellingboe, JW; Hartupee, D; Park, CH; Quagliato, D; Schmid, J; Tanikella, T; White, V | 1 |
| Fluharty, SJ; Hines, J; Sakai, RR | 1 |
| Abernethy, DR; Andrawis, NS; Battle, MM; Burghart, PH; Klamerus, KJ; Mayer, P; Neefe, L; Weinryb, I | 1 |
| Allikmets, K; Franken, A; Häss, G; Parik, T; Skards, J; Viigimaa, M | 1 |
| Brunner, HR; Burnier, M; Maillard, MP; Rossat, J | 1 |
3 trial(s) available for tasosartan and angiotensin ii
| Article | Year |
|---|---|
A pharmacokinetic and pharmacodynamic study of the potential drug interaction between tasosartan and atenolol in patients with stage 1 and 2 essential hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Drug Synergism; Humans; Hypertension; Middle Aged; Pyrimidines; Single-Blind Method; Tetrazoles | 2000 |
Tasosartan and hydroclorothiazide as combination therapy in the treatment of severe essential hypertension: comparison with enalapril. Tasosartan Study Group.
Topics: Analysis of Variance; Angiotensin II; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Pyrimidines; Tetrazoles | 2000 |
Tasosartan, enoltasosartan, and angiotensin II receptor blockade: the confounding role of protein binding.
Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Blood Proteins; Cross-Over Studies; Double-Blind Method; Drug Interactions; Humans; Injections, Intravenous; Male; Protein Binding; Pyrimidines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles | 2000 |
2 other study(ies) available for tasosartan and angiotensin ii
| Article | Year |
|---|---|
Metabolites of the angiotensin II antagonist tasosartan: the importance of a second acidic group.
Topics: Administration, Oral; Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Heart Rate; Hypertension; In Vitro Techniques; Injections, Intravenous; Liver; Models, Molecular; Molecular Conformation; Pyridones; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Structure-Activity Relationship; Tetrazoles | 1998 |
The angiotensin AT(1) receptor antagonist irbesartan has near-peptide affinity and potently blocks receptor signaling.
Topics: Adrenal Glands; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding, Competitive; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Iodine Radioisotopes; Irbesartan; Kidney; Liver; Losartan; Male; PC12 Cells; Pituitary Gland; Pyrimidines; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Signal Transduction; Tetrazoles | 1999 |